Medicare AdvantageCoverageMedium impact
Genetic Testing for Diagnosis and Management of Mental Health Conditions
Blue Cross Blue Shield of Rhode Island·RI · Psychiatry, Primary Care·Provider Update
Effective date
Apr 1, 2022
We identified it
Jun 19, 2026
Summary
BCBS Rhode Island is updating the medical necessity review criteria for GeneSight Psychotropic genetic testing panels for Medicare Advantage plans effective April 1, 2022. The billing team needs to review the updated draft medical policy to understand new coverage requirements.
Action Required
By April 1, 2022: Billing team must review the draft medical policy linked in the provider update to understand new medical necessity criteria for GeneSight Psychotropic panel testing. Update prior authorization and documentation requirements for Medicare Advantage patients receiving genetic testing for mental health conditions. Verify coverage criteria before submitting claims to avoid denials.